Click on image to view larger version.

Fig. 4. Mitf expression and OV regionalization are lost in
Pax2-/-; Pax6-/- embryos.
Immunohistochemical staining of serial, 6 µm cryosections of E9.5
(A-B,E-F,I-J,M-N) and E11.5 (C,D,G,H,K,L,O,P) using antibodies against Pax2
and Pax6 (A-D), Mitf (E-H), Chx10 (I-L) and Otx2 (M-P). (A) Pax2 (green) and
Pax6 (red) are expressed throughout the wild-type E9.5 OV. (C) At E11.5, Pax6
expression (green) is found in all compartments of the eye, but Pax2 (red) is
mainly restricted to the ventral NR and RPE and the optic stalk. Both Pax2 and
Pax6 are absent in Pax2-/-; Pax6-/-
OVs at both stages (B and D). The E9.5 wild-type OV expresses Mitf
predominantly in the proximal regions (E). At E11.5, Mitf expression is
confined to the RPE (G). Mitf fails to be expressed in
Pax2-/-; Pax6-/- OVs at both stages
(F,H). The presumptive NR is marked by the Chx10-positive distal domain at
E9.5 in both the wild-type (I) and the Pax2-/-;
Pax6-/- OVs (J), but seems to be expanded dorsally in the
mutant OV (J, arrow). At E11.5, Chx10 is confined to the NR region in the wild
type (K) and to the distal OV in Pax2-/-;
Pax6-/- OVs (L). The proximal expression of Otx2 in the wild
type at E9.5 (M) appears expanded ventrally in the mutant OV (N, arrow). The
Otx2 expression becomes restricted to the RPE domain at E11.5 in wild type
(O), but remains co-expressed with the Chx10 positive distal OV in
Pax2-/-; Pax6-/- mutants (P). lv, lens
vesicle; ov, optic vesicle; os, optic stalk; nr, neural retina; rpe, retinal
pigmented epithelium; se, surface ectoderm